Skip to main content

Table 4 Effect of Matrine salvianolic acid B salt on GSH, MDA and SOD in rats

From: Hepatoprotective effect of Matrine salvianolic acid B salt on Carbon Tetrachloride-Induced Hepatic Fibrosis

Treatment Doses
(mg/kg)
GSH
(mg/gprotein)
MDA
(nmol/mgprotein)
SOD
(U/mg protein)
Normal control —— 3.00 ± 0.14 1.03 ± 0.22 262.95 ± 30.43
CCl4 —— 1.85 ± 0.28## 3.00 ± 0.45## 151.95 ± 20.25##
Matrine + CCl4 50 2.36 ± 0.53** 2.52 ± 0.87 151.74 ± 11.44
Salvianolic acid B + CCl4 150 2.16 ± 0.65 2.12 ± 0.43** 159.85 ± 22.28
  25 2.28 ± 0.59* 2.58 ± 0.62 169.94 ± 25.16
Matrine salvianolic acid B Salt + CCl4 50 2.48 ± 0.33** 2.11 ± 0.31** 184.65 ± 24.90**ab
  100 2.63 ± 0.29**b 1.79 ± 0.43**a 191.71 ± 48.32**ac
Fu fang bie jia ruan gan pian + CCl4 780 2.52 ± 0.32** 1.76 ± 0.76** 171.39 ± 28.90
  1. Data is expressed as the mean±SD (n = 12).
  2. ##p < 0.01 vs. the normal control group; *p < 0.05, **p < 0.01 vs. the CCl4-treated group;
  3. ap < 0.01 vs. the Matrine group; bp < 0.05, cp < 0.01 vs. the Salvianolic acid B group.